Squarepoint’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
VPC
EP
VCM
YCM
IC
EAM
Squarepoint's PASG Position: Q1 2026 in Review
Squarepoint sold out of Passage Bio (PASG) in Q1 2026, closing a stake of 10,799 shares — an estimated $127K sold.
Squarepoint first reported a position in PASG in Q3 2020 and held it in 16 quarters. The position peaked at $923K in Q1 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.
- Squarepoint reported no remaining Passage Bio position as of Q1 2026 after selling out during the quarter.
- Squarepoint sold 10,799 Passage Bio shares in Q1 2026, an estimated $127K.
- Squarepoint first reported a position in Passage Bio in Q3 2020 and held it in 16 quarters.
- Squarepoint's Passage Bio position peaked at $923K in Q1 2021.
- 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.